glp 1 receptor agonists for type 2 diabetes GLP-1RAs Reduce External Eating Behavior with Current Insights, Advantages and Challenges
Description
While the study was observational and cannot prove causation, its large sample size and rigorous matching lend weight to the results
This review also addresses recent advances in the development of other dual and triple receptor agonists
2024 November 24, 2024
5 Future research outlook Over a relatively short period, obesity is a significant public health problem rising
doi: 10.1038/s41591-022-01707-4 78 US National Institutes of Health
